Facebook
X
LinkedIn
ForwardDrug Conviction Data in KASPER: What is a Prescriber to Do?
Target Audience
This activity is designed for prescribers of controlled substances including physicians, nurse practitioners, dentists, and any other interested healthcare professionals.
Learning Objectives
Kentucky Senate Bill 32 and Drug Conviction Data in KASPER: What Have We Learned?
Upon completion of this education activity, participants will be able to:
- Discuss implications of SB 32 that made drug conviction data available in KASPER effective July 1, 2018
- Review results of Kentucky prescriber and dispenser survey on intent to use drug conviction data in KASPER
- Assess current data regarding the use of drug conviction data in KASPER by prescribers and dispensers
Drug Conviction Data in KASPER: What Does it Mean?
Upon completion of this education activity, participants will be able to:
- Describe the types of drug-related charges in Kentucky
- Review example drug conviction data and describe its content and interpretation
- Identify limitations of drug conviction data
- Evaluate nuances of interpreting drug conviction data and legal implications
Drug Conviction Data in KASPER: What Should I Do?
Upon completion of this education activity, participants will be able to:
- Discuss the impact of criminal conviction data on prescribers’ attitudes and resulting patient health outcomes
- Use example vignettes to interpret drug conviction data in the context of patient care
- Identify strategies for making sound decisions when prescribing controlled substances to prevent unintended consequences
Patricia R. Freeman, RPh, PhD, FAPhA
Associate Professor and Director
Center for the Advancement of Pharmacy Practice
University of Kentucky College of Pharmacy
Lexington, Kentucky
Dana L. Quesinberry, JD, DrPH
Assistant Professor, Associate Director of the KIPRC
Kentucky Injury Prevention and Research Center - University of Kentucky
Disclosure
The speaker, planners, or reviewers do not have any relevant financial relationships to disclose.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Acknowledgment
This project was supported by Grant No. 2017-PM-BX-K026 (Data-Driven Responses to Prescription Drug Misuse in Kentucky) awarded by the Bureau of Justice Assistance (BJA) to the Kentucky Injury Prevention and Research Center as bona fide agent for the Kentucky Department for Public Health.
The BJA is a component of the Department of Justice’s Office of Justice Program, which includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office of Victims Crime, and the SMART Office.
Viewpoints or opinions in these programs are those of the authors and do not necessarily represent the official position or policies of the US Department of Justice.
In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This Enduring activity is designated for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
- 1.50 ANCC (UK Healthcare CECentral)
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.50 nursing contact hour(s).
- 1.50 Dentistry/KDAThis Enduring course meets regulatory requirements for 1.50 credit(s) as permitted by 201 KAR 8:532 for dentists and 201 KAR 8:562 for dental hygienists.
- 1.50 ParticipationUK Healthcare CECentral certifies this activity for 1.50 hour(s) of participation.